Chen Xiangning, Liu Yimei, Cue Joan, Nimgaonkar Mira Han Vishwajit, Weinberger Daniel, Han Shizhong, Zhao Zhongming, Chen Jingchun
The university of Texas Health Science Center at Houston.
Director and CEO, Lieber Institute for Brain Development, Johns Hopkins School of Medicine: Departments of Psychiatry, Neurology, Neuroscience and Genetic Medicine.
Res Sq. 2024 Mar 7:rs.3.rs-4001384. doi: 10.21203/rs.3.rs-4001384/v1.
Recent GWASs have demonstrated that comorbid disorders share genetic liabilities. But whether and how these shared liabilities can be used for the classification and differentiation of comorbid disorders remains unclear. In this study, we use polygenic risk scores (PRSs) estimated from 42 comorbid traits and the deep neural networks (DNN) architecture to classify and differentiate schizophrenia (SCZ), bipolar disorder (BIP) and major depressive disorder (MDD). Multiple PRSs were obtained for individuals from the schizophrenia (SCZ) (cases = 6,317, controls = 7,240), bipolar disorder (BIP) (cases = 2,634, controls 4,425) and major depressive disorder (MDD) (cases = 1,704, controls = 3,357) datasets, and classification models were constructed with and without the inclusion of PRSs of the target (SCZ, BIP or MDD). Models with the inclusion of target PRSs performed well as expected. Surprisingly, we found that SCZ could be classified with only the PRSs from 35 comorbid traits (not including the target SCZ and directly related traits) (accuracy 0.760 ± 0.007, AUC 0.843 ± 0.005). Similar results were obtained for BIP (33 traits, accuracy 0.768 ± 0.007, AUC 0.848 ± 0.009), and MDD (36 traits, accuracy 0.794 ± 0.010, AUC 0.869 ± 0.004). Furthermore, these PRSs from comorbid traits alone could effectively differentiate unaffected controls, SCZ, BIP, and MDD patients (average categorical accuracy 0.861 ± 0.003, average AUC 0.961 ± 0.041). These results suggest that the shared liabilities from comorbid traits alone may be sufficient to classify SCZ, BIP and MDD. More importantly, these results imply that a data-driven and objective diagnosis and differentiation of SCZ, BIP and MDD may be feasible.
近期的全基因组关联研究(GWASs)表明,共病障碍具有共同的遗传易感性。但这些共同的易感性能否以及如何用于共病障碍的分类和鉴别仍不清楚。在本研究中,我们使用从42种共病特征估计得到的多基因风险评分(PRSs)以及深度神经网络(DNN)架构对精神分裂症(SCZ)、双相情感障碍(BIP)和重度抑郁症(MDD)进行分类和鉴别。我们为精神分裂症(SCZ)(病例 = 6317,对照 = 7240)、双相情感障碍(BIP)(病例 = 2634,对照 = 4425)和重度抑郁症(MDD)(病例 = 1704,对照 = 3357)数据集的个体获取了多个PRSs,并构建了包含和不包含目标(SCZ、BIP或MDD)PRSs的分类模型。包含目标PRSs的模型表现如预期般良好。令人惊讶的是,我们发现仅使用来自35种共病特征(不包括目标SCZ和直接相关特征)的PRSs就能对SCZ进行分类(准确率0.760±0.007,曲线下面积[AUC] 0.843±0.005)。对于BIP(33种特征,准确率0.768±0.007,AUC 0.848±0.009)和MDD(36种特征,准确率0.794±0.010,AUC 0.869±0.004)也获得了类似结果。此外,仅这些来自共病特征的PRSs就能有效区分未患病对照、SCZ、BIP和MDD患者(平均分类准确率0.861±